(Q44100466)

English

1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Joseph Knoll

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ildikó Miklya

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Berta Knoll

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Takuya Yasusa

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Seiichiro Shimazu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Fumio Yoneda

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1975-1984

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Trace amines: identification of a family of mammalian G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: rationale for prophylactic (-)deprenyl (selegiline) medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

(-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

(-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901968-9

7 January 2021

Identifiers

10.1016/S0024-3205(02)01968-9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44100466&oldid=2106592394"